Patrys Limited Issues New Shares to Strengthen Financial Position
I'm PortAI, I can summarize articles.
Patrys Limited has issued 308,362,535 fully paid ordinary shares at $0.001 each to sophisticated and professional investors, as part of a placement to strengthen its financial position in the biotechnology sector. This action complies with the Corporations Act and reflects the company's ongoing efforts to secure funding. Patrys Limited, based in Melbourne, focuses on developing its deoxymab platform of cell-penetrating antibodies for various therapeutic indications. The current market cap is A$3.09M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments